// NATURE NEWS — SPAZIO & SCIENZA
Biomarkers that predict improved outcomes after perioperative immune-based therapy for lung cancer
This is a summary of: Cascone, T. et al. Biomarkers of nivolumab benefit in resectable non-small cell lung cancer. Nature https://doi.org/10.1038/s41586-026-10925-6 (2026).
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
Prices may be subject to local taxes which are calculated during checkout
‘Expert opinion’ is published under a CC BY 4.0 licence; Figure 1 is published under a CC BY-NC-ND 4.0 licence.
Sung, H. et al. CA Cancer J. Clin. 76, e70090 (2026).
Article
PubMed
Google Scholar
Article
PubMed
Google Scholar
Provencio, M. et al. Lancet Oncol. 25, 1453–1464 (2024).
Article
PubMed
Google Scholar